VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma. J Hematol Oncol. 2018 01 31; 11(1):15.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
B7-H1 Antigen
Female
Humans
Lymphoma, Extranodal NK-T-Cell
Male
Middle Aged
Neoplasm Recurrence, Local
Treatment Outcome
authors with profiles
KEN HE YOUNG